Page last updated: 2024-11-04

diclofenac sodium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diclofenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to relieve pain and reduce inflammation. It is a derivative of phenylacetic acid and was first synthesized in 1963 by a team of researchers at Ciba-Geigy (now Novartis). The synthesis involves several steps, starting with the reaction of 2,6-dichloroaniline with acetic anhydride to form 2,6-dichloroacetanilide. This intermediate is then reacted with ethyl 2-chloro-2-phenylacetate to give the desired compound. Diclofenac sodium inhibits the production of prostaglandins, which are inflammatory mediators. This action contributes to its pain-relieving and anti-inflammatory effects. The compound is available in various formulations, including tablets, capsules, topical gels, and injections. Diclofenac sodium is widely studied due to its effectiveness in treating a range of conditions, including pain from osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Research focuses on exploring its therapeutic potential in other conditions like chronic pain, migraines, and certain types of cancer. However, like other NSAIDs, diclofenac sodium can cause side effects such as gastrointestinal problems, cardiovascular complications, and renal impairment. Consequently, ongoing research investigates ways to reduce its adverse effects and improve its safety profile.'

diclofenac(1-) : The conjugate base of diclofenac. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Diclofenac Sodium: The sodium form of DICLOFENAC. It is used for its analgesic and anti-inflammatory properties. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diclofenac sodium : The sodium salt of diclofenac. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3032
CHEBI ID48311
MeSH IDM0006287
PubMed CID5018304
CHEMBL ID1034
CHEBI ID4509
SCHEMBL ID24009
MeSH IDM0006287

Synonyms (235)

Synonym
orthophen
voltaren-xr
solaraze
AB00053454
STK177318
NCGC00021336-04
NCGC00021336-03
CHEBI:48311
diclofenac(1-)
{2-[(2,6-dichlorophenyl)amino]phenyl}acetate
AKOS000305881
sodium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
sodium; [2-(2,6-dichloro-phenylamino)-phenyl]-acetate
bdbm50174201
2-[2-(2,6-dichloroanilino)phenyl]acetate
NCGC00021336-05
NCGC00021336-09
AB00053454-16
AB00053454_17
AB00053454_18
AB00053454_19
Q27121136
nsc755403
nsc-755403
benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, ion(1-)
DTXSID201189538
86522-08-9
voldal
delphinac
effekton
diclofenac sod
deflamat
dicloreum
ecofenac
lexobene
benfofen
abitren
dealgic
gp-45840
diclophlogont
xenid
diclomax
primofenac
rewodina
duravolten
nsc-756725
CHEMBL1034
MLS001148587
HMS3393M05
kriplex
ccris 1909
sodium (2-((2,6-dichlorophenyl)amino)phenyl)acetate
ortofen
sodium (o-(2,6-dichloroanilino)phenyl) acetate
blesin
gp 45840
novapirina
voltaren
valetan
pennsaid
einecs 239-346-4
tsudohmin
vurdon
allvoran
vonafec
ba 47210
delphimix
acetic acid, o-(2,6-dichloroanilino)phenyl-, monosodium salt
benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monosodium salt
batafil
neriodin
urigon
dichronic
anthraxiton
prophenatin
voltarene
diclophenac sodium
voltaren ophthalmic
delimon
feloran
EU-0100441
diclofenac sodium salt
sodium dichlofenac
lopac-d-6899
NCGC00017082-01
cas-15307-79-6
NCGC00015361-01
diclofenac, sodium
BIM-0051341.0001
MLS001423970
MLS000758255
smr000449318
benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, monosodium salt [cas]
diclofenac sodium (jp17/usp)
15307-79-6
voltaren (tn)
D00904
NCGC00094648-01
NCGC00094648-02
MLS000028386 ,
smr000058567
diclofenac sodium
SPECTRUM1500237
NCGC00093858-01
NCGC00093858-02
(o-(2,6-dichloroanilino)phenyl)acetic acid sodium salt
sodium (o-(2,6-dichloroanilino)phenyl)acetate
2-((2,6-dichlorophenyl)amino)benzeneacetic acid monosodium salt
sodium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
(o-(2,6-dichloroanilino)phenyl)acetic acid monosodium salt
CHEBI:4509 ,
sodium (o-((2,6-dichlorophenyl)amino)phenyl)acetate
sodium diclofenac
STK400073
NCGC00015361-02
MLS002222163
HMS2091M06
D 6899
HMS2051M05
AC-1487
2-[(2,6-dichlorophenyl)amino]benzeneacetic acid sodium
NCGC00015361-04
AKOS000310014
HMS500N14
D2508
sodium 2-(2,6-dichloroanilino)phenylacetate
2-(2,6-dichloroanilino)phenylacetic acid sodium salt
HMS1569H10
HMS1920E16
NCGC00017082-02
sodium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
A809387
AKOS005267222
HMS2096H10
HMS3261I04
diclofenac sodium injection
unii-qtg126297q
diclofenac sodium [usan:usp:jan]
nsc 756725
assaren
berifen
qtg126297q ,
ec 239-346-4
voltaren gel
tds 943
dyloject
diclofenac sodium topical gel
dic075v
NCGC00253928-01
tox21_300265
2-[(2,6-dichlorophenyl)amino]benzeneacetic acid sodium salt
BCP9000605
tox21_110770
dtxsid3037208 ,
dtxcid1017208
sodium 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate
HMS2236D03
HMS2235O06
CCG-100765
CCG-39754
NCGC00017082-03
NCGC00015361-03
rhumalgan
MLS003882590
BCP0726000303
KUC112363N
ksc-322-017
FT-0624732
LP00441
diclofenac sodium [usan]
diclofenac sodium component of arthrotec
sodium [o-(2,6-dichloroanilino)phenyl]acetate
diclofenac sodium [green book]
diclofenac sodium [usp monograph]
diclofenac sodium [mart.]
arthrotec component diclofenac sodium
diclofenac sodium [usp-rs]
diclofenac sodium [vandf]
diclofenac sodium [jan]
dicloflex
diclofenac sodium salt [mi]
diclofenac sodium [orange book]
diclofenac sodium [who-dd]
diclofenac sodium [ep monograph]
S1903
HMS3371J05
HMS3369K11
HY-15037
diclofenac (sodium)
sodium 2-(2,6-dichloroanilino)-phenylacetate
KPHWPUGNDIVLNH-UHFFFAOYSA-M
sodium 2-[(2,6-dichlorophenyl)amino]phenylacetate
sodium 2-[(2,6-dichlorophenyl)-amino]-phenylacetate
sodium 2-[(2,6-dichlorophenyl)-amino]-phenyl-acetate
sodium 2-[(2,6-dichlorophenyl)-amino]phenylacetate
NC00015
SCHEMBL24009
NCGC00021125-03
tox21_110770_1
KS-5038
NCGC00261126-01
tox21_500441
REGID_FOR_CID_5018304
AKOS024278942
Q-200965
HMS3650B13
OPERA_ID_564
benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, monosodium salt
mfcd00082251
HMS3655A22
diclofenac sodium 1.0 mg/ml in methanol (as free acid)
cpd000449318
HMS3713H10
sodium 2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetate
SW196404-3
sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate
diclofenac sodium,(s)
diclofenac sodium 100 microg/ml in acetonitrile
BCP02915
Q12430631
sodium;2-[2-(2,6-dichloroanilino)phenyl]acetic acid
SDCCGSBI-0050426.P002
HMS3884C16
D78205
D-181
sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate.
diclofenac for system suitability
BD166162
benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, sodium salt (1:1)
voltaren arthritis pain
diclofenac sodium (ep monograph)
diclofenac sodium (usp-rs)
monosodium 2-(2,6-dichlorophenylamino)phenylacetate
diclofenac sodium (usp monograph)
diclofenac sodium (mart.)

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" All S-NO-diclofenac derivatives acted as orally bioavailable prodrugs, producing significant levels of diclofenac in plasma within 15 min after oral administration to mice."( Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs.
Bandarage, UK; Chen, L; Fang, X; Garvey, DS; Glavin, A; Janero, DR; Letts, LG; Mercer, GJ; Saha, JK; Schroeder, JD; Shumway, MJ; Tam, SW, 2000
)
0.31
"A new series of novel benzimidazole derivatives containing substituted pyrid-2-yl moiety and polyhydroxy sugar conjugated to the N-benzimidazole moiety has been synthesized and evaluated as orally bioavailable anti-inflammatory agents with anti-ulcerogenic activity."( Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
Biuomy, AR; El-Nezhawy, AO; Hassan, FS; Ismaiel, AK; Omar, HA, 2013
)
0.39
"An early prediction of solubility in physiological media (PBS, SGF and SIF) is useful to predict qualitatively bioavailability and absorption of lead candidates."( Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Bharate, SS; Vishwakarma, RA, 2015
)
0.42
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Naringenin, naringenin chalcone, and quercetin all showed strong antiallergic activity after intravenous dosing (0."( In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
Boix Montañés, A; Escribano-Ferrer, E; Garcia-Sala, X; Lamuela-Raventos, RM; Queralt Regué, J, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
monocarboxylic acid anionA carboxylic acid anion formed when the carboxy group of a monocarboxylic acid is deprotonated.
organic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (67)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
EWS/FLI fusion proteinHomo sapiens (human)Potency20.69990.001310.157742.8575AID1259252; AID1259253; AID1259255
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency19.90540.140911.194039.8107AID2451
Chain A, Ferritin light chainEquus caballus (horse)Potency35.48135.623417.292931.6228AID2323
LuciferasePhotinus pyralis (common eastern firefly)Potency13.45910.007215.758889.3584AID588342
endonuclease IVEscherichia coliPotency6.30960.707912.432431.6228AID1708
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency16.93013.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency42.56030.006038.004119,952.5996AID1159521; AID1159523
GLS proteinHomo sapiens (human)Potency22.38720.35487.935539.8107AID624146
AR proteinHomo sapiens (human)Potency36.12770.000221.22318,912.5098AID743035; AID743063
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency15.71430.00137.762544.6684AID914; AID915
thyroid stimulating hormone receptorHomo sapiens (human)Potency15.84890.001318.074339.8107AID926
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency12.58930.28189.721235.4813AID2326
retinoid X nuclear receptor alphaHomo sapiens (human)Potency21.26060.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency43.55600.001530.607315,848.9004AID1224819; AID1224820; AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency76.95880.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency24.11400.000229.305416,493.5996AID743069; AID743075; AID743078; AID743079
GVesicular stomatitis virusPotency24.54540.01238.964839.8107AID1645842
glucocerebrosidaseHomo sapiens (human)Potency1.58490.01268.156944.6684AID2101
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency7.88590.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency21.31380.023723.228263.5986AID743223
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency0.02000.035520.977089.1251AID504332
activating transcription factor 6Homo sapiens (human)Potency8.46560.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency24.227819.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency21.87240.057821.109761.2679AID1159526
Bloom syndrome protein isoform 1Homo sapiens (human)Potency0.00250.540617.639296.1227AID2364; AID2528
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency56.23410.036619.637650.1187AID1466; AID2242
cytochrome P450 2C9 precursorHomo sapiens (human)Potency4.76410.00636.904339.8107AID883
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency30.89560.042027.378961.6448AID743210
eyes absent homolog 2 isoform aHomo sapiens (human)Potency158.48901.199814.641950.1187AID488837
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency15.37050.000627.21521,122.0200AID743202; AID743219
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency39.81070.050127.073689.1251AID588590
gemininHomo sapiens (human)Potency0.23110.004611.374133.4983AID624297
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency9.11860.031610.279239.8107AID884; AID885
M-phase phosphoprotein 8Homo sapiens (human)Potency0.79430.177824.735279.4328AID488949
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Interferon betaHomo sapiens (human)Potency24.54540.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency24.54540.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency68.58960.002319.595674.0614AID651631; AID720552
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency56.23413.548118.039535.4813AID1466
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Potency56.23413.548118.039535.4813AID1466
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Alpha-synucleinHomo sapiens (human)Potency25.92070.56239.398525.1189AID652106
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency4.76410.00638.235039.8107AID883
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
TAR DNA-binding protein 43Homo sapiens (human)Potency15.84891.778316.208135.4813AID652104
GABA theta subunitRattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency24.54540.01238.964839.8107AID1645842
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency9.31441.000012.224831.6228AID885
cytochrome P450 2C9, partialHomo sapiens (human)Potency24.54540.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serum paraoxonase/arylesterase 1Homo sapiens (human)Ki805.00009.00009.00009.0000AID1799750
Prostaglandin G/H synthase 1Ovis aries (sheep)IC50 (µMol)2.63670.00032.177410.0000AID1403471; AID1517245; AID1592992; AID1667491; AID1739492; AID1763090; AID598520; AID658647; AID744753
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)0.82000.00010.995010.0000AID1403472; AID1517246; AID1592998; AID1667492; AID1739493; AID1763091
Aldo-keto reductase family 1 member C3Homo sapiens (human)IC50 (µMol)2.60000.05002.207010.0000AID257049
Prostaglandin G/H synthase 2Ovis aries (sheep)IC50 (µMol)3.26670.00101.453910.0000AID598521; AID658648; AID744752
Sigma intracellular receptor 2Rattus norvegicus (Norway rat)IC50 (µMol)0.80000.01431.37567.5000AID1403472
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (343)

Processvia Protein(s)Taxonomy
negative regulation of plasma lipoprotein oxidationSerum paraoxonase/arylesterase 1Homo sapiens (human)
cholesterol metabolic processSerum paraoxonase/arylesterase 1Homo sapiens (human)
response to toxic substanceSerum paraoxonase/arylesterase 1Homo sapiens (human)
positive regulation of cholesterol effluxSerum paraoxonase/arylesterase 1Homo sapiens (human)
carboxylic acid catabolic processSerum paraoxonase/arylesterase 1Homo sapiens (human)
organophosphate catabolic processSerum paraoxonase/arylesterase 1Homo sapiens (human)
phosphatidylcholine metabolic processSerum paraoxonase/arylesterase 1Homo sapiens (human)
lactone catabolic processSerum paraoxonase/arylesterase 1Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
G protein-coupled receptor signaling pathwayAldo-keto reductase family 1 member C3Homo sapiens (human)
response to nutrientAldo-keto reductase family 1 member C3Homo sapiens (human)
steroid metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of cell population proliferationAldo-keto reductase family 1 member C3Homo sapiens (human)
male gonad developmentAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to starvationAldo-keto reductase family 1 member C3Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
cyclooxygenase pathwayAldo-keto reductase family 1 member C3Homo sapiens (human)
keratinocyte differentiationAldo-keto reductase family 1 member C3Homo sapiens (human)
progesterone metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
retinal metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
macromolecule metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
regulation of retinoic acid receptor signaling pathwayAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionAldo-keto reductase family 1 member C3Homo sapiens (human)
testosterone biosynthetic processAldo-keto reductase family 1 member C3Homo sapiens (human)
renal absorptionAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to calcium ionAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to prostaglandin stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to corticosteroid stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to jasmonic acid stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to prostaglandin D stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
negative regulation of retinoic acid biosynthetic processAldo-keto reductase family 1 member C3Homo sapiens (human)
regulation of testosterone biosynthetic processAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of endothelial cell apoptotic processAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (107)

Processvia Protein(s)Taxonomy
aryldialkylphosphatase activitySerum paraoxonase/arylesterase 1Homo sapiens (human)
arylesterase activitySerum paraoxonase/arylesterase 1Homo sapiens (human)
calcium ion bindingSerum paraoxonase/arylesterase 1Homo sapiens (human)
phospholipid bindingSerum paraoxonase/arylesterase 1Homo sapiens (human)
protein homodimerization activitySerum paraoxonase/arylesterase 1Homo sapiens (human)
acyl-L-homoserine-lactone lactonohydrolase activitySerum paraoxonase/arylesterase 1Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
estradiol 17-beta-dehydrogenase [NAD(P)] activityAldo-keto reductase family 1 member C3Homo sapiens (human)
all-trans-retinol dehydrogenase (NAD+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptorAldo-keto reductase family 1 member C3Homo sapiens (human)
phenanthrene 9,10-monooxygenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
dihydrotestosterone 17-beta-dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin D2 11-ketoreductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
ketoreductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin-F synthase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
15-hydroxyprostaglandin-D dehydrogenase (NADP+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
androsterone dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
5alpha-androstane-3beta,17beta-diol dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
testosterone dehydrogenase (NAD+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
androstan-3-alpha,17-beta-diol dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
testosterone 17-beta-dehydrogenase (NADP+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
ketosteroid monooxygenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
Delta4-3-oxosteroid 5beta-reductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
bile acid bindingAldo-keto reductase family 1 member C3Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (63)

Processvia Protein(s)Taxonomy
extracellular regionSerum paraoxonase/arylesterase 1Homo sapiens (human)
extracellular spaceSerum paraoxonase/arylesterase 1Homo sapiens (human)
endoplasmic reticulum membraneSerum paraoxonase/arylesterase 1Homo sapiens (human)
extracellular exosomeSerum paraoxonase/arylesterase 1Homo sapiens (human)
blood microparticleSerum paraoxonase/arylesterase 1Homo sapiens (human)
high-density lipoprotein particleSerum paraoxonase/arylesterase 1Homo sapiens (human)
spherical high-density lipoprotein particleSerum paraoxonase/arylesterase 1Homo sapiens (human)
extracellular spaceSerum paraoxonase/arylesterase 1Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
nucleusAldo-keto reductase family 1 member C3Homo sapiens (human)
cytoplasmAldo-keto reductase family 1 member C3Homo sapiens (human)
cytosolAldo-keto reductase family 1 member C3Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member C3Homo sapiens (human)
cytosolAldo-keto reductase family 1 member C3Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (611)

Assay IDTitleYearJournalArticle
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1799750Paraoxonase Activity Assay from Article 10.1080/14756360802608351: \\Effect of some analgesics on paraoxonase-1 purified from human serum.\\2009Journal of enzyme inhibition and medicinal chemistry, Aug, Volume: 24, Issue:4
Effect of some analgesics on paraoxonase-1 purified from human serum.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1593009Antiinflammatory activity in rat acute inflammation model assessed as inhibition of formalin-induced paw edema at 5 mg/kg, po measured after 4 hrs relative to celecoxib2019European journal of medicinal chemistry, Apr-01, Volume: 167Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
AID664969Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr prior to carrageenan-challenge measured after 1 hr2012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID1739492Inhibition of ovine COX1 by colorimetric analysis2020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID1243975Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg, po dosed 30 mins before carrageenan challenge and measured 60 mins post carrageenan challenge2015European journal of medicinal chemistry, Aug-28, Volume: 101Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
AID294732Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 60 mins by Eddy's hot plate technique2007European journal of medicinal chemistry, Jun, Volume: 42, Issue:6
Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues.
AID1292781Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 3 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID173360Hypolipidemic action at 500 uM/kg was determined as reduction in total cholesterol in rat plasma2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID1667491Inhibition of ovine COX1 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition and measured after 2 mins by EIA2020Bioorganic & medicinal chemistry, 04-01, Volume: 28, Issue:7
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
AID477054Analgesic activity in Swiss albino mouse assessed as inhibition of acetic acid-induced writhing at 50 mg/kg, po administered 2 hrs before acetic acid challenge measured after 20 mins relative to control2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID257049Inhibition of recombinant human AKR1C32005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
AID477053Antiinflammatory activity in ip dosed Wistar rat assessed as inhibition of carrageenan-induced paw edema administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID735616Antiinflammatory activity in albino rat assessed as inhibition of formalin-induced paw edema at 20 mg/kg, po administered 1 hr prior to formalin challenge measured after 2 hrs by plethysmometric analysis relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID1193497Thermodynamic equilibrium solubility, log S of the compound PBS at pH 7.4 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1292439Terminal half life in healthy volunteer (7 volunteers) at 50 mg, iv administered as single dose over 2 mins infusion1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1275838Antibiofilm activity against Candida guilliermondii ATCC 6260 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1275866Potentiation of anidulafungin-induced antibiofilm activity against Candida guilliermondii a83 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1211803Drug excretion in iv dosed Wistar rat assessed as compound excreted into bile2013Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
AID371934Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 10 mg/kg, po after 30 mins2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID592579Metabolic stability in rat liver microsomes assessed as compound remaining after 30 mins by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1846824Acute ulcerogenic activity in 18 hrs fasted Wistar rat at 60 mg/kg, po treated for 6 hrs relative to control2021European journal of medicinal chemistry, Oct-05, Volume: 221Contemporary advances of cyclic molecules proposed for inflammation.
AID1474816Anti-inflammatory activity against carrageenan-induced paw oedema in albino rat assessed as paw thickness at 100 mg/kg measured at 6 hrs post dose (Rvb = 0.92 +/- 0.03 cm)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID280212Solubility at neutral pH2007Journal of medicinal chemistry, Mar-08, Volume: 50, Issue:5
Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
AID1055525Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg administered 30 mins prior to carrageenan-challenge measured after 3 hrs by plethysmographic analysis relative to control2013European journal of medicinal chemistry, , Volume: 70Synthesis, anticonvulsant and anti-inflammatory studies of new 1,4-dihydropyridin-4-yl-phenoxyacetohydrazones.
AID1275853Antibiofilm activity against Candida albicans ATCC 90028 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1175391Inhibition of human TRPV1 overexpressed in BEAS-2B cells assessed as residual activity at 250 uM after 30 mins by Fluo-4 AM fluorescence assay2014Bioorganic & medicinal chemistry letters, Dec-15, Volume: 24, Issue:24
Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.
AID729513Antiinflammatory activity against carrageenan-induced paw edema in Sprague-Dawley rat assessed as inhibition of paw volume at 20 mg/kg, po measured 180 mins post challenge by plethysmometer2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
AID1221816Cytotoxicity against HEK293 cells expressing UGT1A3 assessed as decrease in cell viability at 0.1 mM by MTT assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1220787Fraction unbound in dog plasma by ultracentrifugation method2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1430596Antirheumatoid arthritic activity in patient assessed as visual analogue scale at 50 mg, po bid for 8 weeks (Rvb = 78.25 +/- 11.25 No_unit)2017ACS medicinal chemistry letters, May-11, Volume: 8, Issue:5
Curcumin May (Not) Defy Science.
AID184535Mortality caused by the compound in rats after administration at 240 uM/kg for 4 days2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID675012Antiinflammatory activity in po dosed albino rat acute inflammatory model assessed as inhibition of formalin-induced paw edema compound administered 1 hr post challenge measured after 1 hr2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID251629Antiinflammatory activity against Albino rat dosed at 100 mg/kg (3h)2005Bioorganic & medicinal chemistry letters, Aug-01, Volume: 15, Issue:15
Synthesis and biological evaluation of novel angularly fused polycyclic coumarins.
AID1221818Cytotoxicity against HEK293 cells expressing UGT1A3 assessed as decrease in cell viability by measuring intracellular ATP content at 0.1 mM by CellTiter-Glo luminescent assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1763091Inhibition of human recombinant COX-2 using arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition by colorimetric analysis
AID1292780Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 2.5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1292798Oral bioavailability in healthy subject (7 subjects) at 50 mg administered as single dose1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1275823Potentiation of anidulafungin-induced antibiofilm activity against Candida glabrata ATCC 15126 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292428Tmax in healthy volunteer (3 volunteers) assessed as 3'-hydroxy-4'-methoxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1275863Potentiation of anidulafungin-induced antibiofilm activity against Candida guilliermondii a410 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1275803Antibiofilm activity against Candida guilliermondii a83 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID270020Gastric toxicity in rat at 40 mg/kg, iv2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
AID1275875Potentiation of anidulafungin-induced antibiofilm activity against Candida glabrata ATCC 15126 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1275791Antibiofilm activity against Candida albicans 17a18 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID371940Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 10 mg/kg, po after 3 hrs2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID416935Analgesic activity in C57BL/6 mouse assessed as decrease in acetic acid-induced writhing at 100 mg/kg, po administered 1 hr before acetic acid challenge measured during 30 mins of acetic acid challenge relative to control2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, analgesic and anti-inflammatory activities of novel 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles.
AID1221779Cytotoxicity against mock transfected HEK293 cells assessed as decrease in cell viability by measuring intracellular ATP content at 0.1 mM by CellTiter-Glo luminescent assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID735613Antiinflammatory activity in albino rat assessed as inhibition of formalin-induced paw edema at 20 mg/kg, po qd administered 7 days measured on day 1 post formalin challenge by plethysmometric analysis relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID1439748Antiinflammatory activity assessed as inhibition of heat-induced egg albumin denaturation at 1 mM after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents.
AID1667492Inhibition of human recombinant COX2 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition and measured after 2 mins by EIA2020Bioorganic & medicinal chemistry, 04-01, Volume: 28, Issue:7
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
AID658650Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced foot paw edema at 100 mg/kg, ip measured after 2 hrs2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
AID1275788Antibiofilm activity against Candida albicans ATCC 24433 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID324003Antiinflammatory activity against carrageenan-induced paw edema in orally dosed Wistar rat after 1 hr relative to control2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
AID664972Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, po administered 1 hr prior to carrageenan-challenge measured after 3 hrs2012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID658653Antiinflammatory activity in ip dosed rat assessed as inhibition of carrageenan-induced foot paw edema measured after 2 hrs2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
AID1292783Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 4 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID483272Antiinflammatory activity in Wistar rat assessed as reduction of carrageenan-induced increase in paw volume at 30 mg/kg, po after 3 hrs2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives.
AID1193499Thermodynamic equilibrium solubility, log S of the compound simulated intestinal fluid at pH 6.8 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID661540In vitro antiarthritic activity assessed as inhibition of bovine serum albumin denaturation at 800 ug/mL incubated for 20 mins at 37 degC following rise in temperature up to 57 degC for 3 mins by UV-Visible spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis, study on anti-arthritic, anti-inflammatory activity and toxicity of some novel bis-oxy cyclophane diamides.
AID1292413Apparent elimination half life in healthy volunteer (3 volunteers) assessed as 5-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID625312Ulcerogenicity in fasted Wistar rat assessed as ulceration at 300 mg/kg, po administered every 2 hrs2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Synthesis and anti-inflammatory activity of some new 4,5-dihydro-1,5-diaryl-1H-pyrazole-3-substituted-heteroazole derivatives.
AID675015Antiinflammatory activity in albino rat sub-acute inflammatory model assessed as inhibition of turpentine-induced granuloma pouch at 10 mg/kg, po administered 1 hr post challenge for 7 consecutive days measured at day 8 of challenge2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID1193883Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw edema administered 30 mins prior to carrageenan challenge measured after 2 hrs relative to control2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Rapid 'one-pot' synthesis of a novel benzimidazole-5-carboxylate and its hydrazone derivatives as potential anti-inflammatory and antimicrobial agents.
AID1292785Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID515194Antiinflammatory activity in albino rat assessed as reduction of carrageenan-induced paw volume at 10 mg/kg, po administered 30 mins before carrageenan challenge measured after 60 mins by plethysmograph (Rvb = 0.333 +/- 0.033 ml)2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline.
AID1220797Volume of distribution at steady state in human2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID289578Analgesic activity against acetic acid-induced writhing in Swiss Albino mouse assessed as protection at 2.5 mg/kg, po2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis of some bioactive 2-bromo-5-methoxy-N'-[4-(aryl)-1,3-thiazol-2-yl]benzohydrazide derivatives.
AID1292776Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 0.5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID574422Inhibition of wild type-TTR expressed in Escherichia coli assessed as amyloid fibril formation at pH 4.4 at 7. 2 uM after 72 hrs by acid-mediated aggregation assay relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
A competition assay to identify amyloidogenesis inhibitors by monitoring the fluorescence emitted by the covalent attachment of a stilbene derivative to transthyretin.
AID1275786Antibiofilm activity against Candida albicans ATCC 90028 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID324006Analgesic activity against acetic acid-induced writhing in Swiss Albino mouse at 10 mg/kg, po after 25 mins relative to control2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
AID1437586Antiinflammatory activity assessed as inhibition of heat-induced albumin denaturation at 5 uM after 20 mins by spectrophotometric method relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID346295Antiinflammatory activity against formalin-induced paw edema in anaesthetized Albino rat acute inflammatory model at 10 mg/kg, po dosed 1 hr before formalin challenge assessed after 4 hrs2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID477059Acute toxicity in ip dosed Wistar rat assessed as mortality after 24 hrs2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID478504Antiinflammatory activity in Sprague-Dawley rat assessed as protection against carrageenan-induced paw edema at 20 mg/kg, po administered 1 hr before carrageenan challenge measured after 2 hrs2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID1763096Inhibition of LPS-induced TNFalpha production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
AID1292417Total drug excretion in healthy volunteer (3 volunteers) urine assessed as 3'-hydroxy diclofenac at 100 mg, po administered as single dose measured over 96 hrs by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1275797Antibiofilm activity against Candida glabrata 18a10 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID293132Toxicity in rat assessed as ulcerogenic potential2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Synthesis and biological evaluation of some 5-ethoxycarbonyl-6-isopropylamino-4-(substitutedphenyl)aminopyrimidines as potent analgesic and anti-inflammatory agents.
AID1292796Elimination rate constant in healthy subject (7 subjects) at 50 mg, po administered as single dose1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1220791Ratio of drug level in blood to plasma in monkey2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID23265Partition coefficient (logD7.4)1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Synthesis and quantitative structure-activity relationships of diclofenac analogues.
AID491008Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw oedema at 20 mmol/kg, ip administered 1 hr before carrageenan challenge measured after 2 hrs2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID744753Inhibition of ovine COX1-mediated prostaglandin alpha production by enzyme immuno assay2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
AID324005Antiinflammatory activity against carrageenan-induced paw edema in orally dosed Wistar rat after 3 hrs relative to control2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
AID1275847Antibiofilm activity against Candida albicans 17a18 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292399Total drug excretion in healthy volunteer (3 volunteers) urine at 100 mg, po administered as single dose measured over 96 hrs by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1437587Antiinflammatory activity assessed as inhibition of heat-induced albumin denaturation at 10 uM after 20 mins by spectrophotometric method relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID515197Antiinflammatory activity in albino rat assessed as reduction of carrageenan-induced paw volume at 10 mg/kg, po administered 30 mins before carrageenan challenge measured after 150 mins by plethysmograph (Rvb = 0.3667 +/- 0.033 ml)2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline.
AID592578Metabolic stability in rat plasma assessed as compound remaining after 120 mins by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID371937Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg, po after 1 hr2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1193494Thermodynamic equilibrium solubility, log S of the compound in simulated gastric fluid at pH 1.2 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1403472Inhibition of recombinant human COX2 assessed as reduction in PGF2alpha production using arachidonic acid as substrate by colorimetric method2018European journal of medicinal chemistry, Jan-20, Volume: 144Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
AID1275850Antibiofilm activity against Candida albicans ATCC 24433 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID324008Gastric-ulcerogenic effect in Wistar rat at 30 mg/kg, po2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
AID1275818Antibiofilm activity against Candida albicans 17a18 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID515193Antiinflammatory activity in albino rat assessed as reduction of carrageenan-induced paw volume at 10 mg/kg, po administered 30 mins before carrageenan challenge measured after 30 mins by plethysmograph (Rvb = 0.333 +/- 0.033 ml)2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline.
AID171176Body weight change after once daily administration at 240 uM/kg for 4 days in rats was determined2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID1275798Antibiofilm activity against Candida glabrata 18a10 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292784Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 4.5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1292786Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 5.5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1593008Antiinflammatory activity in rat acute inflammation model assessed as inhibition of formalin-induced paw edema at 5 mg/kg, po measured after 4 hrs relative to control2019European journal of medicinal chemistry, Apr-01, Volume: 167Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
AID661539In vitro antiarthritic activity assessed as inhibition of bovine serum albumin denaturation at 400 ug/mL incubated for 20 mins at 37 degC following rise in temperature up to 57 degC for 3 mins by UV-Visible spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis, study on anti-arthritic, anti-inflammatory activity and toxicity of some novel bis-oxy cyclophane diamides.
AID1275801Antibiofilm activity against Candida guilliermondii ATCC 6260 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1739495Selectivity index, ratio of IC50 for ovine COX-1 to IC50 for human recombinant COX-22020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID1275886Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans ATCC 90028 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292406Apparent elimination half life in healthy volunteer (3 volunteers) assessed as 4'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292408AUC (0 to 96 hrs) in healthy volunteer (3 volunteers) assessed as 5-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID417467Peripheral analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing response at 20 mg/kg, po administered 30 mins before acetic acid challenge measured after 2 hrs relative to control2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1246493Anti-inflammatory activity assessed as inhibition of bovine serum albumin denaturation at 10 to 500 ug/ml incubated for 15 mins at 37 degC2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis and biological evaluation of new symmetric curcumin derivatives.
AID1292402AUC (0 to infinity) in healthy volunteer (3 volunteers) assessed as 4'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292411Tmax in healthy volunteer (3 volunteers) assessed as 5-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292427Cmax in healthy volunteer (3 volunteers) assessed as 3'-hydroxy-4'-methoxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID25726Area under curve was measured as relative diclofenac from 0-2 hr postdosing.2000Journal of medicinal chemistry, Oct-19, Volume: 43, Issue:21
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs.
AID1292789Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 6.5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID346289Antiinflammatory activity against formalin-induced paw edema in anaesthetized Albino rat acute inflammatory model at 10 mg/kg, po dosed 1 hr before formalin challenge assessed after 1 hr2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID270014Inhibition of COX22006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
AID416933Antiinflammatory activity against carrageenan-induced paw edema in C57BL/6 mouse assessed as increase in paw volume at 100 mg/kg, po administered 1 hr before carrageenan challenge measured 4 hrs after carrageenan challenge relative to control2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, analgesic and anti-inflammatory activities of novel 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles.
AID477061Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 0.169 M/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID1275809Antibiofilm activity against Candida albicans ATCC 10231 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID558037Cytotoxicity against human SVG-A cells2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Identification and characterization of mefloquine efficacy against JC virus in vitro.
AID194137Inhibition of inflammatory hind paw edema, induced by Mycobacterium butyricum in rats; ED40 in umol/kg po1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Synthesis and quantitative structure-activity relationships of diclofenac analogues.
AID1474820Analgesic activity in albino rat model of thermal-induced nociception assessed as tail withdrawal latency time at 100 mg/kg, po measured at 180 mins post dose by tail immersion test (Rvb = 2.62 +/- 0.13 min)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID1275829Potentiation of anidulafungin-induced antibiofilm activity against Candida guilliermondii ATCC 6260 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1193884Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw edema administered 30 mins prior to carrageenan challenge measured after 3 hrs relative to control2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Rapid 'one-pot' synthesis of a novel benzimidazole-5-carboxylate and its hydrazone derivatives as potential anti-inflammatory and antimicrobial agents.
AID1846837Antiulcer activity against ulceration induced albino Wistar rat assessed as ulcerogenic index pretreated daily at 25 mg/kg for 4 days followed by 24 hrs fasting prior to pylorus ligation measured after 4 hrs2021European journal of medicinal chemistry, Oct-05, Volume: 221Contemporary advances of cyclic molecules proposed for inflammation.
AID112732Antiinflammatory activity, administered ip at 150 uM/kg dose was determined against carrageenan-induced mice paw edema model2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID491109Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw oedema at 18 mmol/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID173361Hypolipidemic action at 500 uM/kg was determined as reduction in triglycerides in rat plasma2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID1275783Antibiofilm activity against Candida albicans ATCC 10231 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID592583Aqueous solubility of the compound in 0.1 M citric acid buffer at pH 3 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1193492Thermodynamic equilibrium solubility, log S of the compound in water at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID693845Antiinflammatory activity in Wistar albino rat assessed as inhibition of carrageenan-induced paw edema at 25 mg/kg, po after 2 hrs (Rvb = 1.11 +/- 0.02%)2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
AID592577Metabolic stability in rat plasma assessed as compound remaining after 60 mins by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID675009Antiinflammatory activity in albino rat acute inflammatory model assessed as inhibition of formalin-induced paw edema at 10 mg/kg, po administered 1 hr post challenge measured after 1 hr2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID280220Intrinsic solubility at 25 degC2007Journal of medicinal chemistry, Mar-08, Volume: 50, Issue:5
Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
AID1292419AUC (0 to 96 hrs) in healthy volunteer (3 volunteers) assessed as 4',5-dihydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292770AUC (0 to infinity) in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1275820Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans 17a18 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1275827Antibiofilm activity against Candida guilliermondii ATCC 6260 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID744752Inhibition of ovine COX2-mediated prostaglandin alpha production by enzyme immuno assay2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
AID1292420AUC (0 to infinity) in healthy volunteer (3 volunteers) assessed as 4',5-dihydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1288031Antiinflammatory activity assessed as inhibition of albumin denaturation after 15 mins by BSA assay2016Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7
Biological evaluation and molecular docking studies of new curcuminoid derivatives: Synthesis and characterization.
AID417463Central analgesic activity in Swiss albino mouse assessed as thermal stimuli reaction time at 20 mg/kg, po after 60 mins by hot plate method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1125014Antiinflammatory activity in Swiss Albino mouse assessed as inhibition of carrageenan-induced IL-6 production in serum at 25 mg/kg, po administered 30 mins before carrageenan challenge after 30 mins by ELISA (Rvb = 23.8 +/- 2.5 ng/ml)2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
AID1292400Apparent elimination half life in healthy volunteer (3 volunteers) at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID592587Partition coefficient, log P of the compound in octanol/0.2 M phosphate buffer at pH 7.4 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1763097Inhibition of LPS-induced IL-6 production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
AID371930Analgesic activity in Wister albino rat at 10 mg/kg, po after 2 hrs by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1220796Drug metabolism in bile duct-cannulated rat assessed as glucuronide concentration in bile and urine at 0.2 mg/kg, iv up to 24 hrs by LC/MS/MS analysis2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1155773Analgesic activity in albino mouse assessed as inhibition of acetic acid-induced writhing at 10 mg/kg, po administered 1 hr prior challenge relative to control2014European journal of medicinal chemistry, Jul-23, Volume: 82Syntheses, characterization and evaluation of novel 2,6-diarylpiperidin-4-ones as potential analgesic-antipyretic agents.
AID1193495Thermodynamic equilibrium solubility, log S of the compound in simulated intestinal fluid at pH 6.8 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1292438Terminal half life in healthy volunteer (7 volunteers) at 50 mg, po administered as single dose1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1275844Antibiofilm activity against Candida glabrata ATCC 15126 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID558036Therapeutic index, ratio of TC50 for JC polyomavirus M1/SVEdelta infected human SVG-A cells to EC50 for JC polyomavirus M1/SVEdelta2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Identification and characterization of mefloquine efficacy against JC virus in vitro.
AID1474821Analgesic activity in albino rat model of thermal-induced nociception assessed as tail withdrawal latency time at 100 mg/kg, po measured at 240 mins post dose by tail immersion test (Rvb = 2.62 +/- 0.13 min)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID1292779Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 2 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID591401Aqueous solubility of the compound in 0.1 M phosphate buffer at pH 5.2 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID625309Analgesic activity in Wistar rat assessed as inhibition of acetic acid-induced writhing at 100 mg/kg, po administered 1 hr before acetic acid challenge measured after 30 mins relative to control2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Synthesis and anti-inflammatory activity of some new 4,5-dihydro-1,5-diaryl-1H-pyrazole-3-substituted-heteroazole derivatives.
AID1292423Total drug excretion in healthy volunteer (3 volunteers) urine assessed as 4',5-dihydroxy diclofenac at 100 mg, po administered as single dose measured over 96 hrs by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1474818Analgesic activity in albino rat model of thermal-induced nociception assessed as tail withdrawal latency time at 100 mg/kg, po measured at 60 mins post dose by tail immersion test (Rvb = 2.62 +/- 0.11 min)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID1437582Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, po preincubated for 1 hr followed by carrageenan challenge measured at 3 hrs by plethysmometer relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID1739535Cytotoxicity against PMA/LPS-challenged human THP1 cells assessed as reduction in cell viability incubated for 24 hrs by MTS assay2020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID270017Anti-inflammatory activity against carrageenan-induced paw edema in Sprague-Dawley rat at 3 mg/kg, iv after 5 hrs2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
AID675014Antiinflammatory activity in albino rat sub-acute inflammatory model assessed as inhibition of formalin-induced paw edema at 10 mg/kg, po administered 1 hr post challenge for 7 consecutive days measured at day 8 of challenge2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID346301Antiinflammatory activity against turpentine oil-induced granuloma pouch in anaesthetized Albino rat sub-acute inflammatory model at 10 mg/kg, po 1 hr before turpentine oil challenge for 7 days assessed after 8 days2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID592595Gastrointestinal toxicity in Wistar rat assessed as ulcer area of 1-3 mm diameter at 50 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID536434Antiinflammatory activity in Swiss albino mouse macrophage assessed as inhibition of LPS-induced IL1-beta production at 1 ug/ml treated 30 mins before LPS challenge measured after 24 hrs by ELISA2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-inflammatory activity of derivatives of coumarino-lignoid, cleomiscosin A and its methyl ether.
AID478508Analgesic activity in Swiss mouse at 20 mg/kg, po assessed as reaction time after 90 mins by hot plate method2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID536430Antiinflammatory activity in Swiss albino mouse macrophage assessed as inhibition of LPS-induced TNFalpha production at 1 ug/ml treated 30 mins before LPS challenge measured after 24 hrs by ELISA2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-inflammatory activity of derivatives of coumarino-lignoid, cleomiscosin A and its methyl ether.
AID371926Analgesic activity in Wister albino rat at 10 mg/kg, po after 30 mins by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1292418Apparent elimination half life in healthy volunteer (3 volunteers) assessed as 3'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1517246Inhibition of human recombinant COX-2 by EIA method2019European journal of medicinal chemistry, Dec-01, Volume: 183New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
AID491108Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw oedema at 12 mmol/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID193609Gastric toxicity was measured in rats2000Journal of medicinal chemistry, Oct-19, Volume: 43, Issue:21
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs.
AID477058Gastrointestinal toxicity in Wistar rat assessed as length of elongated ulcer at equimolar po dose relative 0.169 M/kg diclofenac sodium qd for 5 days measured after 10 hrs last post dose2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID371927Analgesic activity in Wister albino rat at 20 mg/kg, po after 30 mins by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1537227Anti-inflammatory activity in arachidonic acid-induced CD-1 mouse ear edema model assessed as inhibition of ear edema thickness at 1% administered topically immediately after arachidonic acid treatment and measured 1 hr post arachidonic acid treatment rel2019Journal of natural products, 02-22, Volume: 82, Issue:2
In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
AID729515Antiinflammatory activity against carrageenan-induced paw edema in Sprague-Dawley rat assessed as paw volume at 20 mg/kg, po measured 60 mins post challenge by plethysmometer (Rvb = 0.90 +/- 0.03 ml)2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
AID1365247Anti-inflammatory activity using bovine serum albumin and egg albumin proteins incubated at 37 degC for 20 mins and then heated to 95 degC for 20 mins by UV-visible Spectrophotometry based protein denaturation method2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Synthesis, pharmacological activities and molecular docking studies of pyrazolyltriazoles as anti-bacterial and anti-inflammatory agents.
AID675013Antiinflammatory activity in albino rat sub-acute inflammatory model assessed as inhibition of formalin-induced paw edema at 10 mg/kg, po administered 1 hr post challenge for 7 consecutive days measured at day 1 of challenge2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID1846823Anti-inflammatory activity against Cotton pellets induced granuloma in Albino rat at 20 mg/kg, po administered for 7 days measured on day 8 by measuring pellet weight relative to control2021European journal of medicinal chemistry, Oct-05, Volume: 221Contemporary advances of cyclic molecules proposed for inflammation.
AID1220785Fraction unbound in rat plasma by ultracentrifugation method2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID417464Central analgesic activity in Swiss albino mouse assessed as thermal stimuli reaction time at 20 mg/kg, po after 90 mins by hot plate method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1126559Antiinflammatory activity in Wister rat assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, po administered 1 hr before carrageenan challenge measured after 3 hrs by plethysmograph analysis2014European journal of medicinal chemistry, May-06, Volume: 78Synthesis and biological evaluation of N-dehydrodipeptidyl-N,N'-dicyclohexylurea analogs.
AID1365245Anti-inflammatory activity at 50 ug/ml using bovine serum albumin and egg albumin proteins incubated at 37 degC for 20 mins and then heated to 95 degC for 20 mins by UV-visible Spectrophotometry based protein denaturation method2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Synthesis, pharmacological activities and molecular docking studies of pyrazolyltriazoles as anti-bacterial and anti-inflammatory agents.
AID1193498Thermodynamic equilibrium solubility, log S of the compound simulated gastric fluid at pH 1.2 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID417466Peripheral analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing response at 20 mg/kg, po administered 30 mins before acetic acid challenge measured after 1 hr relative to control2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID417462Central analgesic activity in Swiss albino mouse assessed as thermal stimuli reaction time at 20 mg/kg, po after 30 mins by hot plate method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1125012Antiinflammatory activity in Swiss Albino mouse assessed as inhibition of carrageenan-induced paw edema at 25 mg/kg, po administered 30 mins before carrageenan challenge relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
AID346314Analgesic activity in Albino rat assessed as tail withdrawal response at 10 mg/kg, po after 2 hrs2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID1292401AUC (0 to 96 hrs) in healthy volunteer (3 volunteers) assessed as 4'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1275883Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans ATCC 24433 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292763First order inter-compartment transfer rate constant from tissue to central compartment in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1292398Tmax in healthy volunteer (3 volunteers) at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID661537In vitro antiarthritic activity assessed as inhibition of bovine serum albumin denaturation at 100 ug/mL incubated for 20 mins at 37 degC following rise in temperature up to 57 degC for 3 mins by UV-Visible spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis, study on anti-arthritic, anti-inflammatory activity and toxicity of some novel bis-oxy cyclophane diamides.
AID371942Toxicity in Wistar albino rat assessed as ulcer index at 20 mg/kg, ip administered once daily for 3 days2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1166517Antiinflammatory activity in rat paw edema model assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr post carrageenan challenge measured after 4 hrs2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
AID1055526Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg administered 30 mins prior to carrageenan-challenge measured after 2 hrs by plethysmographic analysis relative to control2013European journal of medicinal chemistry, , Volume: 70Synthesis, anticonvulsant and anti-inflammatory studies of new 1,4-dihydropyridin-4-yl-phenoxyacetohydrazones.
AID1763092Selectivity index, ratio of IC50 for ovine COX-1 to IC50 for human recombinant COX-2
AID1221775Cytotoxicity against HEK293 cells expressing UGT1A4 assessed as decrease in cell viability by measuring intracellular ATP content at 0.1 mM by CellTiter-Glo luminescent assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1532666Anti-inflammatory activity in formalin-induced Swiss albino mouse assessed as reduction in paw edema volume at 10 mg/kg, ip pretreated for 30 mins followed by formalin addition relative to control2019European journal of medicinal chemistry, Jan-15, Volume: 162Anti-inflammatory activity of triazine derivatives: A systematic review.
AID615468Antiinflammatory activity assessed as inhibition of albumin denaturation at 100 ug/ml by UV-visible spectrophotometry2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening.
AID536643Analgesic activity in Swiss albino mouse assessed as inhibition of heat-induced paw licking or jumping behavior at 10 mg/kg, po administered after 15 sec of heat challenge measured after 90 mins post dose by Eddy's hot plate method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.
AID746389Antiinflammatory activity against carrageenan-induced Wistar rat paw edema model assessed as mean paw volume at 50 mg/kg, po after 1 hr (Rvb =1.29 +/- 0.01 ml)2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents.
AID1275789Antibiofilm activity against Candida albicans ATCC 24433 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID417459Antiinflammatory activity in Sprague-Dawley rat assessed as protection against carrageenan-induced hind paw edema at 20 mg/kg, po administered 1 hr before carrageenan challenge measured after 1 hr2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID661538In vitro antiarthritic activity assessed as inhibition of bovine serum albumin denaturation at 200 ug/mL incubated for 20 mins at 37 degC following rise in temperature up to 57 degC for 3 mins by UV-Visible spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis, study on anti-arthritic, anti-inflammatory activity and toxicity of some novel bis-oxy cyclophane diamides.
AID515195Antiinflammatory activity in albino rat assessed as reduction of carrageenan-induced paw volume at 10 mg/kg, po administered 30 mins before carrageenan challenge measured after 90 mins by plethysmograph (Rvb = 0.3667 +/- 0.033 ml)2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline.
AID346315Analgesic activity in Albino rat assessed as tail withdrawal response at 10 mg/kg, po after 3 hrs2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID598524Selectivity index, ratio of IC50 for ovine COX1 to IC50 for ovine COX22011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
AID592580Metabolic stability in rat liver microsomes assessed as compound remaining after 60 mins by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1474819Analgesic activity in albino rat model of thermal-induced nociception assessed as tail withdrawal latency time at 100 mg/kg, po measured at 120 mins post dose by tail immersion test (Rvb = 2.63 +/- 0.15 min)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID693846Antiinflammatory activity in Wistar albino rat assessed as inhibition of carrageenan-induced paw edema at 25 mg/kg, po after 3 hrs (Rvb = 1.08 +/- 0.41%)2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
AID478509Analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing at 20 mg/kg, po after 30 mins2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID1763095Antioxidant activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced intracellular ROS production preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by DCFH-DA staining based fluorescence analysis
AID664968Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr prior to carrageenan-challenge measured after 0.5 hrs2012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID515196Antiinflammatory activity in albino rat assessed as reduction of carrageenan-induced paw volume at 10 mg/kg, po administered 30 mins before carrageenan challenge measured after 120 mins by plethysmograph (Rvb = 0.367 +/- 0.033 ml)2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline.
AID483271Antiinflammatory activity in Wistar rat assessed as reduction of carrageenan-induced increase in paw volume at 30 mg/kg, po after 2 hrs2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives.
AID1292403Cmax in healthy volunteer (3 volunteers) assessed as 4'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292766Elimination rate constant in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID478503Antiinflammatory activity in Sprague-Dawley rat assessed as protection against carrageenan-induced paw edema at 20 mg/kg, po administered 1 hr before carrageenan challenge measured after 1 hr2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID1592992Inhibition of ovine COX1 catalytic activity using arachidonic acid as substrate pre-incubated for 10 mins followed by substrate addition and measured after 2 mins by ELISA method2019European journal of medicinal chemistry, Apr-01, Volume: 167Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
AID1292794Tlag in healthy subject (7 subjects) at 50 mg, po administered as single dose1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID346293Antiinflammatory activity against formalin-induced paw edema in anaesthetized Albino rat acute inflammatory model at 10 mg/kg, po dosed 1 hr before formalin challenge assessed after 3 hrs2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID1220798Half life in human2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1275835Potentiation of anidulafungin-induced antibiofilm activity against Candida guilliermondii a410 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID735612Antiinflammatory activity in albino rat assessed as inhibition of formalin-induced paw edema at 20 mg/kg, po qd administered 7 days measured on day 8 post formalin challenge by plethysmometric analysis relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID280213Solubility in 0.5 M NaCl at 25 degC by shake flask method2007Journal of medicinal chemistry, Mar-08, Volume: 50, Issue:5
Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
AID735607Analgesic activity in albino rat assessed as increase in tail withdrawal latency at 20 mg/kg, po after 4 hrs relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID744751Selectivity index, ratio of IC50 for ovine COX1 to IC50 for ovine COX22013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
AID693844Antiinflammatory activity in Wistar albino rat assessed as inhibition of carrageenan-induced paw edema at 25 mg/kg, po after 1 hr (Rvb = 0.85 +/- 0.01%)2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
AID280219Kinetic solubility at 25 degC2007Journal of medicinal chemistry, Mar-08, Volume: 50, Issue:5
Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
AID1275812Antibiofilm activity against Candida albicans ATCC 90028 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID417460Antiinflammatory activity in Sprague-Dawley rat assessed as protection against carrageenan-induced hind paw edema at 20 mg/kg, po administered 1 hr before carrageenan challenge measured after 2 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1292771Plasma clearance in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID270016Anti-inflammatory activity against carrageenan-induced paw edema in Sprague-Dawley rat at 3 mg/kg, iv after 3 hrs2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
AID417461Antiinflammatory activity in Sprague-Dawley rat assessed as protection against carrageenan-induced hind paw edema at 20 mg/kg, po administered 1 hr before carrageenan challenge measured after 3 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1292765First order inter-compartment transfer rate constant from deep tissue to central compartment in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID664967Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, po administered 1 hr prior to carrageenan-challenge measured after 3 hrs2012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID729514Antiinflammatory activity against carrageenan-induced paw edema in Sprague-Dawley rat assessed as paw volume at 20 mg/kg, po measured 120 mins post challenge by plethysmometer (Rvb = 1.13 +/- 0.04 ml)2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
AID1437588Antiinflammatory activity assessed as inhibition of heat-induced albumin denaturation after 20 mins by spectrophotometric method2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID1166515Antiinflammatory activity in rat paw edema model assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr post carrageenan challenge measured after 2 hrs2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
AID28640Level of plasma diclofenac in mice after oral administration of prodrug2000Journal of medicinal chemistry, Oct-19, Volume: 43, Issue:21
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs.
AID436660Analgesic activity in mouse assessed as protection against acetic acid-induced writhing at 5 mg/kg, sc administered 30 mins before acetic acid challenge measured after 4 hrs relative to control2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
AID592586Aqueous solubility of the compound in 0.1 M alkaline borate buffer at pH 9 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID762702Antiinflammatory activity against heat-induced albumin denaturation at 100 mg/ml preincubated for 15 mins before heat induction by UV-vis spectrophotometer analysis2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID245703Analgesic activity against Swiss albino mice dosed at 100 mg/kg and activity calculated as percentage maximum possible effect (% MPE); No activity 2005Bioorganic & medicinal chemistry letters, Aug-01, Volume: 15, Issue:15
Synthesis and biological evaluation of novel angularly fused polycyclic coumarins.
AID270015Selectivity index, IC50 for COX1 over IC50 for COX22006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
AID658647Inhibition of ovine COX1 by enzyme immuno assay2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
AID371932Analgesic activity in Wister albino rat at 10 mg/kg, po after 3 hrs by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1220788Fraction unbound in human plasma by ultracentrifugation method2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1275785Antibiofilm activity against Candida albicans ATCC 90028 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID346291Antiinflammatory activity against formalin-induced paw edema in anaesthetized Albino rat acute inflammatory model at 10 mg/kg, po dosed 1 hr before formalin challenge assessed after 2 hrs2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID478507Analgesic activity in Swiss mouse at 20 mg/kg, po assessed as reaction time after 60 mins by hot plate method2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID1275841Antibiofilm activity against Candida glabrata 18a10 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID118143Antiinflammatory activity, administered ip at 150 uM/kg dose was determined against carrageenan-induced mice paw edema model2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID1292769Terminal half life in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1211821Drug excretion in iv dosed human assessed as compound excreted into bile after 8 hrs by T-tube method2013Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
AID648026Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 50 mg/kg after 1 hr by plethysmography relative to control2012European journal of medicinal chemistry, Apr, Volume: 50Design, synthesis, computational and biological evaluation of some new hydrazino derivatives of DHA and pyranopyrazoles.
AID592589Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr before carrageenan challenge measured after 180 mins2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID371931Analgesic activity in Wister albino rat at 20 mg/kg, po after 2 hrs by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID346313Analgesic activity in Albino rat assessed as tail withdrawal response at 10 mg/kg, po after 1 hr2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID1193882Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw edema administered 30 mins prior to carrageenan challenge measured after 1 hr relative to control2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Rapid 'one-pot' synthesis of a novel benzimidazole-5-carboxylate and its hydrazone derivatives as potential anti-inflammatory and antimicrobial agents.
AID1221822Cytotoxicity against HEK293 cells expressing UGT1A3 assessed as decrease in cell viability at 0.1 mM measured at 24 hrs by MTT assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID735608Analgesic activity in albino rat assessed as increase in tail withdrawal latency at 20 mg/kg, po after 2 hrs relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID478512Analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing at 20 mg/kg, po after 3 hrs2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID598516Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of carrageenan-induced foot paw oedema at 100 mg/kg, ip after 1 hr by plethysmometer analysis relative to control2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
AID1763098Inhibition of LPS-induced 15(S)-HETE production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by ELISA
AID477050Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 75 mg/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID1243974Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg, po dosed 30 mins before carrageenan challenge and measured 30 mins post carrageenan challenge2015European journal of medicinal chemistry, Aug-28, Volume: 101Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
AID1517247Selectivity index, ratio of IC50 for ovine COX-1 to IC50 for human recombinant COX-22019European journal of medicinal chemistry, Dec-01, Volume: 183New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
AID160713In vitro inhibition of bovine prostaglandin G/H synthase, using bovine seminal vesicle microsomal preparations; IC50 in umol/L1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Synthesis and quantitative structure-activity relationships of diclofenac analogues.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1292767Fast disposition half life in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1221793Cytotoxicity against human hepatocytes assessed as decrease in cell viability at 0.1 mM measured at 6 hrs by MTT assay in presence of acyl glucuronidation inhibitor (-)-borneol2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID592585Aqueous solubility of the compound in 0.2 M phosphate buffer at pH 7.4 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1221812Activity of human UGT1A4 expressed in HEK293 cells assessed as enzyme-mediated diclofenac acyl-beta-D-glucuronide formation at 0.1 mM measured at 24 hrs by LC-MS/MS analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1220790Ratio of drug level in blood to plasma in rat2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID478505Antiinflammatory activity in Sprague-Dawley rat assessed as protection against carrageenan-induced paw edema at 20 mg/kg, po administered 1 hr before carrageenan challenge measured after 3 hrs2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID1517245Inhibition of ovine COX-1 by EIA method2019European journal of medicinal chemistry, Dec-01, Volume: 183New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
AID169240Incidence of melena defecation was recorded 24 hrs of last treatment given once daily for 4 days; Positive2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID1292396AUC (0 to infinity) in healthy volunteer (3 volunteers) at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID536642Analgesic activity in Swiss albino mouse assessed as inhibition of heat-induced paw licking or jumping behavior at 10 mg/kg, po administered after 15 sec of heat challenge measured after 60 mins post dose by Eddy's hot plate method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.
AID1403471Inhibition of ovine COX1 assessed as reduction in PGF2alpha production using arachidonic acid as substrate by colorimetric method2018European journal of medicinal chemistry, Jan-20, Volume: 144Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
AID1220800Drug metabolism in bile duct-cannulated monkey assessed as glucuronide concentration in bile and urine at 0.2 mg/kg, iv up to 24 hrs by LC/MS/MS analysis2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID536644Toxicity in albino rat at 20 mg/kg, ip assessed as ulcer index at 10 mg/kg, po after 17 hrs2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.
AID1125019Acute ulcerogenic effect in Swiss Albino mouse assessed as damage in gastric mucosa by measuring histological scores at 50 mg/kg, po by hematoxylin and eosin staining2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
AID1211879Unbound biliary clearance in iv dosed Wistar rat2013Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
AID1175392Inhibition of human TRPV1 overexpressed in BEAS-2B cells assessed as residual activity at 50 uM after 30 mins by Fluo-4 AM fluorescence assay2014Bioorganic & medicinal chemistry letters, Dec-15, Volume: 24, Issue:24
Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.
AID1220784Fraction unbound in mouse plasma by ultracentrifugation method2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1275824Antibiofilm activity against Candida glabrata 18a10 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292764First order inter-compartment transfer rate constant from central to deep tissue compartment in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID416934Antiinflammatory activity against carrageenan-induced paw edema in C57BL/6 mouse assessed as inhibition of paw edema at 100 mg/kg, po administered 1 hr before carrageenan challenge measured 4 hrs after carrageenan challenge relative to control2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, analgesic and anti-inflammatory activities of novel 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles.
AID1221800Cytotoxicity against HEK293 cells expressing UGT assessed as cell viability at 1 mM relative to control2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1275814Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans ATCC 90028 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1275811Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans ATCC 10231 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1166514Antiinflammatory activity in rat paw edema model assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr post carrageenan challenge measured after 1 hr2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
AID1292424Apparent elimination half life in healthy volunteer (3 volunteers) assessed as 4',5-dihydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292797Terminal half life in healthy subject (7 subjects) at 50 mg, po administered as single dose1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1292778Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 1.5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID478506Analgesic activity in Swiss mouse at 20 mg/kg, po assessed as reaction time after 30 mins by hot plate method2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID1220789Ratio of drug level in blood to plasma in mouse2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID658649Selectivity ratio of IC50 for ovine COX1 to IC50 for ovine COX22012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
AID491009Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw oedema at 20 mmol/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID1055527Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg administered 30 mins prior to carrageenan-challenge measured after 1 hr by plethysmographic analysis relative to control2013European journal of medicinal chemistry, , Volume: 70Synthesis, anticonvulsant and anti-inflammatory studies of new 1,4-dihydropyridin-4-yl-phenoxyacetohydrazones.
AID1292431AUC (0 to 72 hrs) in healthy volunteer assessed as 3'-hydroxy-4'-methoxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292792Cmax in healthy subject (7 subjects) at 50 mg, po administered as single dose1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1275869Potentiation of anidulafungin-induced antibiofilm activity against Candida guilliermondii ATCC 6260 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292429Total drug excretion in healthy volunteer (3 volunteers) urine assessed as 3'-hydroxy-4'-methoxy diclofenac at 100 mg, po administered as single dose measured over 96 hrs by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID408486Inhibition of recombinant Curvularia lunata trihydroxynaphthalene reductase2008Bioorganic & medicinal chemistry, Jun-01, Volume: 16, Issue:11
Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.
AID746386Analgesic activity in rat at 25 mg/kg, po after 60 mins by radiant heat tail flick method relative to control2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents.
AID1220794Plasma clearance in human2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID483274Antiinflammatory activity in Wistar rat assessed as reduction of carrageenan-induced increase in paw volume at 30 mg/kg, po after 24 hrs2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives.
AID1221777Cytotoxicity against mock transfected HEK293 cells assessed as decrease in cell viability at 0.1 mM by MTT assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1365246Anti-inflammatory activity at 100 ug/ml using bovine serum albumin and egg albumin proteins incubated at 37 degC for 20 mins and then heated to 95 degC for 20 mins by UV-visible Spectrophotometry based protein denaturation method2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Synthesis, pharmacological activities and molecular docking studies of pyrazolyltriazoles as anti-bacterial and anti-inflammatory agents.
AID436659Analgesic activity in mouse assessed as protection against acetic acid-induced writhing at 5 mg/kg, sc administered 30 mins before acetic acid challenge measured after 3 hrs relative to control2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
AID1292795AUC (0 to infinity) in healthy subject (7 subjects) at 50 mg, po administered as single dose1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1474815Anti-inflammatory activity against carrageenan-induced paw oedema in albino rat assessed as paw thickness at 100 mg/kg measured at 3 hrs post dose (Rvb = 0.93 +/- 0.02 cm)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID1275792Antibiofilm activity against Candida albicans 17a18 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1474817Analgesic activity in albino rat model of thermal-induced nociception assessed as tail withdrawal latency time at 100 mg/kg, po measured immediately by tail immersion test (Rvb = 2.60 +/- 0.14 min)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID598519Antiinflammatory activity in ip dosed Sprague-Dawley rat assessed as inhibition of carrageenan-induced foot paw oedema after 2 hrs by plethysmometer analysis2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
AID536640Antiinflammatory activity in Wister albino rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, po administered 30 mins before carrageenan treatment measured after 3 hrs by plethysmometric analysis2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.
AID1739493Inhibition of human recombinant COX2 by colorimetric analysis2020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID1292415Cmax in healthy volunteer (3 volunteers) assessed as 3'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292762First order inter-compartment transfer rate constant from central to tissue compartment in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID371938Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 10 mg/kg, po after 2 hrs2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1292409AUC (0 to infinity) in healthy volunteer (3 volunteers) assessed as 5-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID483273Antiinflammatory activity in Wistar rat assessed as reduction of carrageenan-induced increase in paw volume at 30 mg/kg, po after 4 hrs2010Bioorganic & medicinal chemistry letters, Jun-15, Volume: 20, Issue:12
Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives.
AID1739508Inhibition of COX2 in LPS-stimulated human HT-29 cells assessed as 6-keto-PGF1alpha production at 300 uM measured after 48 hrs by ELISA2020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID744750Antiinflammatory activity in ip dosed Sprague-Dawley rat assessed as inhibition of carrageenan-induced paw edema measured after 2 hrs plethysmometric analysis2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
AID1211860Unbound biliary clearance in iv dosed human after 8 hrs by T-tube method2013Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
AID598520Inhibition of ovine COX1 assessed as PGF2alpha production from PGH2 after 5 mins by enzyme immunoassay2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
AID1401256Antiinflammatory activity in Swiss Webster mouse assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, ip preincubated for 30 mins followed by carrageenan challenge measured after 60 mins by plethysmometer2018European journal of medicinal chemistry, Jan-01, Volume: 1431,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
AID1292414AUC (0 to infinity) in healthy volunteer (3 volunteers) assessed as 3'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1220786Fraction unbound in monkey plasma by ultracentrifugation method2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID675016Ulcerogenic activity in albino rat assessed as hyperemia at 300 mg/kg/day administered as equal doses at 0 and 12 hrs for three consecutive days measured at 6 hrs post last dose2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID371928Analgesic activity in Wister albino rat at 10 mg/kg, po after 1 hr by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID491111Antiinflammatory activity in ip dosed albino rat assessed as inhibition of carrageenan-induced paw oedema administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID477049Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID491007Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw oedema at 20 mmol/kg, ip administered 1 hr before carrageenan challenge measured after 1 hr2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID333734Antiinflammatory activity against carrageenan-induced paw edema in Wistar rat at 25 mg/kg, po administered 1 hr before inflammation induction measured after 3 hrs of carrageenan challenge relative to control2004Journal of natural products, Dec, Volume: 67, Issue:12
New acylated iridoid glucosides from Vitex altissima.
AID1292799Cmax in healthy subject (7 subjects) at 50 mg, iv measured after 5 mins1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1772561Aqueous solubility of compound in PBS buffer at 200 uM at pH 7.4 incubated for 2 hrs2021European journal of medicinal chemistry, Nov-05, Volume: 223Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
AID1292430Apparent elimination half life in healthy volunteer (3 volunteers) assessed as 3'-hydroxy-4'-methoxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1193493Thermodynamic equilibrium solubility, log S of the compound in PBS at pH 7.4 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1292397Cmax in healthy volunteer (3 volunteers) at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1592998Inhibition of human recombinant COX2 catalytic activity using arachidonic acid as substrate pre-incubated for 10 mins followed by substrate addition and measured after 2 mins by ELISA method2019European journal of medicinal chemistry, Apr-01, Volume: 167Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
AID1292404Tmax in healthy volunteer (3 volunteers) assessed as 4'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1125013Antiinflammatory activity in Swiss Albino mouse assessed as inhibition of carrageenan-induced TNFalpha production in serum at 25 mg/kg, po administered 30 mins before carrageenan challenge after 30 mins by ELISA (Rvb = 15.48 +/- 0.31 ng/ml)2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
AID1221790Cytotoxicity against human hepatocytes assessed as decrease in cell viability by measuring intracellular ATP content at 0.1 mM measured at 6 hrs by CellTiter-Glo luminescent assay in presence of acyl glucuronidation inhibitor (-)-borneol2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID436657Analgesic activity in mouse assessed as protection against acetic acid-induced writhing at 5 mg/kg, sc administered 30 mins before acetic acid challenge measured after 1 hr relative to control2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
AID644994Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 50 mg/kg after 2 hrs by plethysmography relative to control2012European journal of medicinal chemistry, Apr, Volume: 50Design, synthesis, computational and biological evaluation of some new hydrazino derivatives of DHA and pyranopyrazoles.
AID1292768Slow disposition half life in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID735615Antiinflammatory activity in albino rat assessed as inhibition of formalin-induced paw edema at 20 mg/kg, po administered 1 hr prior to formalin challenge measured after 4 hrs by plethysmometric analysis relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID1474822Analgesic activity in albino rat model of thermal-induced nociception assessed as tail withdrawal latency time at 100 mg/kg, po measured at 300 mins post dose by tail immersion test (Rvb = 2.58 +/- 0.11 min)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID536641Analgesic activity in Swiss albino mouse assessed as inhibition of heat-induced paw licking or jumping behavior at 10 mg/kg, po administered after 15 sec of heat challenge measured after 30 mins post dose by Eddy's hot plate method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.
AID270018Gastric toxicity in rat at 20 mg/kg, iv2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
AID735617Antiinflammatory activity in albino rat assessed as inhibition of formalin-induced paw edema at 20 mg/kg, po administered 1 hr prior to formalin challenge measured after 1 hr by plethysmometric analysis relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID20345Level of plasma diclofenac in mice after oral administration2000Journal of medicinal chemistry, Oct-19, Volume: 43, Issue:21
Nitrosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs.
AID468462Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, po administered 1 hr before carrageenan challenge measured after 3 hrs2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis, characterization and biological activities of some new benzo[b]thiophene derivatives.
AID346297Antiinflammatory activity against formalin-induced paw edema in anaesthetized Albino rat sub-acute inflammatory model at 10 mg/kg, po measured on day 12009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID1292421Cmax in healthy volunteer (3 volunteers) assessed as 4',5-dihydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292777Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 1 hr by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID675011Antiinflammatory activity in albino rat acute inflammatory model assessed as inhibition of formalin-induced paw edema at 10 mg/kg, po administered 1 hr post challenge measured after 4 hr2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID592591Gastrointestinal toxicity in Wistar rat assessed as ulcer index at 50 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID592581Aqueous solubility of the compound in 0.2 M hydrochloric acid buffer at pH 1 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1275856Antibiofilm activity against Candida albicans ATCC 10231 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID661536In vitro antiarthritic activity assessed as inhibition of bovine serum albumin denaturation at 50 ug/mL incubated for 20 mins at 37 degC following rise in temperature up to 57 degC for 3 mins by UV-Visible spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis, study on anti-arthritic, anti-inflammatory activity and toxicity of some novel bis-oxy cyclophane diamides.
AID1275832Potentiation of anidulafungin-induced antibiofilm activity against Candida guilliermondii a83 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292426AUC (0 to infinity) in healthy volunteer (2 volunteers) assessed as 3'-hydroxy-4'-methoxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID478511Analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing at 20 mg/kg, po after 2 hrs2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID293130Analgesic activity in Albino mouse assessed as inhibition of acetic acid-induced writhing at 50 mg/kg, po2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Synthesis and biological evaluation of some 5-ethoxycarbonyl-6-isopropylamino-4-(substitutedphenyl)aminopyrimidines as potent analgesic and anti-inflammatory agents.
AID1437580Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, po preincubated for 1 hr followed by carrageenan challenge measured at 1 hr by plethysmometer relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID1537231Anti-inflammatory activity in tetradecanoylphorbol-13-acetate-induced CD-1 mouse ear edema model assessed as inhibition of ear edema thickness at 1% administered topically immediately after tetradecanoylphorbol-13-acetate treatment and measured 4 hrs post2019Journal of natural products, 02-22, Volume: 82, Issue:2
In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
AID1275795Antibiofilm activity against Candida glabrata ATCC 15126 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1221829Activity of human UGT1A3 expressed in HEK293 cells assessed as enzyme-mediated diclofenac acyl-beta-D-glucuronide formation at 0.1 mM measured at 24 hrs by LC-MS/MS analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1221820Cytotoxicity against HEK293 cells expressing UGT assessed as LDH leakage at 0.1 mM after 6 to 24 hrs by spectrophotometric analysis relative to total cell LDH level2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID477048Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 30 mg/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID1275806Antibiofilm activity against Candida guilliermondii a410 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1403473Selectivity index, ratio of IC50 for ovine COX1 to IC50 for recombinant human COX22018European journal of medicinal chemistry, Jan-20, Volume: 144Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
AID1275903Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans ATCC 10231 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID644995Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 50 mg/kg after 3 hrs by plethysmography relative to control2012European journal of medicinal chemistry, Apr, Volume: 50Design, synthesis, computational and biological evaluation of some new hydrazino derivatives of DHA and pyranopyrazoles.
AID270013Inhibition of COX12006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
AID491112Toxicity in albino rat at 20 mg/kg, ip assessed as ulcer index2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID1220792Ratio of drug level in blood to plasma in dog2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID371939Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg, po after 2 hrs2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1292425AUC (0 to 96 hrs) in healthy volunteer (3 volunteers) assessed as 3'-hydroxy-4'-methoxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1292793Tmax in healthy subject (7 subjects) at 50 mg, po administered as single dose1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1275833Antibiofilm activity against Candida guilliermondii a410 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1275807Antibiofilm activity against Candida guilliermondii a410 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1211871Total biliary clearance in iv dosed Wistar rat2013Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
AID1221783Cytotoxicity against HEK293 cells expressing UGT assessed as decrease in cell viability at 0.1 mM measured up to 72 hrs by MTT assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1292790Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 8 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1275815Antibiofilm activity against Candida albicans ATCC 24433 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID173359Hypolipidemic action at 500 uM/kg was determined as reduction in low density lipoprotein in rat plasma2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID625308Antiinflammatory activity in Wistar rat assessed as protection against carrageenan-induced paw edema at 100 mg/kg, po administered 1 hr before carrageenan challenge measured after 4 hrs relative to control2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Synthesis and anti-inflammatory activity of some new 4,5-dihydro-1,5-diaryl-1H-pyrazole-3-substituted-heteroazole derivatives.
AID1763090Inhibition of ovine COX-1 using arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition by colorimetric analysis
AID1292773Volume of distribution of tissue compartment in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1220783Drug metabolism in human assessed as glucuronide concentration in bile and urine2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID25584Dissociation constant (pKa)1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Synthesis and quantitative structure-activity relationships of diclofenac analogues.
AID324007Gastric-ulcerogenic effect in Wistar rat at 10 mg/kg, po2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
AID592582Aqueous solubility of the compound in 0.1 M hydrochloric acid buffer at pH 1.2 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1275804Antibiofilm activity against Candida guilliermondii a83 by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1763094Inhibition of LPS-induced NO production in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS stimulation and measured after 20 hrs by DAF-FM based fluorescence analysis
AID648025Analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced wriths at 50 mg/kg, po administered 30 mins prior acetic acid challenge measured for 10 mins2012European journal of medicinal chemistry, Apr, Volume: 50Design, synthesis, computational and biological evaluation of some new hydrazino derivatives of DHA and pyranopyrazoles.
AID746388Antiinflammatory activity against carrageenan-induced Wistar rat paw edema model assessed as mean paw volume at 50 mg/kg, po after 2 hrs (Rvb =1.32 +/- 0.001 ml)2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents.
AID1221773Cytotoxicity against HEK293 cells expressing UGT1A4 assessed as decrease in cell viability at 0.1 mM by MTT assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID664977Ulcerogenic activity in fasted albino rat assessed as ulcer index at 50 mg/kg po administered qd for 3 days measured on day 42012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID1221797Cellular uptake in human hepatocytes at 0.1 mM measured at 6 hrs by LC-MS/MS analysis in absence of acyl glucuronidation inhibitor (-)-borneol2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1220795Plasma clearance in po dosed human2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID371933Analgesic activity in Wister albino rat at 20 mg/kg, po after 3 hrs by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1292407AUC (0 to 96 hrs) in healthy volunteer (3 volunteers) assessed as 3'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID675010Antiinflammatory activity in albino rat acute inflammatory model assessed as inhibition of formalin-induced paw edema at 10 mg/kg, po administered 1 hr post challenge measured after 2 hr2012European journal of medicinal chemistry, Sep, Volume: 55Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents.
AID417465Peripheral analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing response at 20 mg/kg, po administered 30 mins before acetic acid challenge measured after 30 mins relative to control2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1437584Antiinflammatory activity assessed as inhibition of heat-induced albumin denaturation at 0.5 uM after 20 mins by spectrophotometric method relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID1275880Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans 17a18 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID346299Antiinflammatory activity against formalin-induced paw edema in anaesthetized Albino rat sub-acute inflammatory model at 10 mg/kg, po for 7 days measured on day 82009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID1221795Cellular uptake in human hepatocytes at 0.1 mM measured at 6 hrs by LC-MS/MS analysis in presence of acyl glucuronidation inhibitor (-)-borneol2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID294731Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 30 mins by Eddy's hot plate technique2007European journal of medicinal chemistry, Jun, Volume: 42, Issue:6
Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues.
AID1275872Potentiation of anidulafungin-induced antibiofilm activity against Candida glabrata 18a10 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1275826Potentiation of anidulafungin-induced antibiofilm activity against Candida glabrata 18a10 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID574424Displacement of S-phenyl 3-(4-hydroxy-3,5-dimethylstyryl)benzothioate from human TTR assessed as fluorescence at 37 degC after 3 hrs2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
A competition assay to identify amyloidogenesis inhibitors by monitoring the fluorescence emitted by the covalent attachment of a stilbene derivative to transthyretin.
AID1220793Ratio of drug level in blood to plasma in human2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1275830Antibiofilm activity against Candida guilliermondii a83 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID658652Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced foot paw edema at 50 mg/kg, ip measured after 2 hrs2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
AID735614Antiinflammatory activity in po dosed albino rat assessed as inhibition of formalin-induced paw edema administered 1 hr prior to formalin challenge measured after 2 hrs by plethysmometric analysis2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID190507Ulcerogenic activity administered once daily at 240 uM/kg for 4 days was determined as no of animals showing perforating ulcers2004Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14
Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity.
AID558029Antiviral activity against JC polyomavirus M1/SVEdelta infected in human SVG-A cells assessed as inhibition of viral replication after 3 days2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Identification and characterization of mefloquine efficacy against JC virus in vitro.
AID1292774Volume of distribution of deep tissue compartment in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1667493Selectivity index, ratio of IC50 of ovine COX-1 to IC50 of human recombinant COX-22020Bioorganic & medicinal chemistry, 04-01, Volume: 28, Issue:7
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
AID1275817Potentiation of anidulafungin-induced antibiofilm activity against Candida albicans ATCC 24433 assessed as anidulafungin-fractional inhibitory concentration index by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID592597Gastrointestinal toxicity in Wistar rat assessed as ulcer area of >3 mm diameter at 50 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1275800Antibiofilm activity against Candida guilliermondii ATCC 6260 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID735611Ulcerogenic activity in albino rat assessed as appearance of hyperemia at 300 mg/kg, po bid administered for 3 days measured after 6 hrs post last dose relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID1292787Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 7 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1243976Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg, po dosed 30 mins before carrageenan challenge and measured 120 mins post carrageenan challenge2015European journal of medicinal chemistry, Aug-28, Volume: 101Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
AID1275904Antibiofilm activity against Candida guilliermondii a83 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1193500Thermodynamic equilibrium solubility, log S of the compound2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1474814Anti-inflammatory activity against carrageenan-induced paw oedema in rat assessed as paw thickness at 100 mg/kg measured immediately (Rvb = 0.98 +/- 0.03 cm)2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
AID1437585Antiinflammatory activity assessed as inhibition of heat-induced albumin denaturation at 1 uM after 20 mins by spectrophotometric method relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID664970Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr prior to carrageenan-challenge measured after 2 hrs2012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID477060Therapeutic index, ED50 for antiinflammatory activity to LD50 for acute toxicity in Wistar rat2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study.
AID1275905Antibiofilm activity against Candida guilliermondii a410 at 0.1 uM to 100 mM after 48 hrs by XTT reduction assay relative to control2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292772Volume of distribution of central compartment in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID1166516Antiinflammatory activity in rat paw edema model assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr post carrageenan challenge measured after 3 hrs2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
AID625311Inhibition of COX2 in human whole blood at 20 uM2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Synthesis and anti-inflammatory activity of some new 4,5-dihydro-1,5-diaryl-1H-pyrazole-3-substituted-heteroazole derivatives.
AID574423Displacement of 4-fluorophenyl 3-(4-hydroxy-3,5-dimethylstyryl)benzoate from recombinant TTR assessed as fluorescence at 37 degC after 3 hrs2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
A competition assay to identify amyloidogenesis inhibitors by monitoring the fluorescence emitted by the covalent attachment of a stilbene derivative to transthyretin.
AID1292405Total drug excretion in healthy volunteer (3 volunteers) urine assessed as 4'-hydroxy diclofenac at 100 mg, po administered as single dose measured over 96 hrs by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID658648Inhibition of ovine COX2 by enzyme immuno assay2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
AID1055528Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg administered 30 mins prior to carrageenan-challenge measured after 30 mins by plethysmographic analysis relative to control2013European journal of medicinal chemistry, , Volume: 70Synthesis, anticonvulsant and anti-inflammatory studies of new 1,4-dihydropyridin-4-yl-phenoxyacetohydrazones.
AID1220801Drug metabolism in bile duct-cannulated dog assessed as glucuronide concentration in bile and urine at 0.2 mg/kg, iv up to 24 hrs by LC/MS/MS analysis2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1292788Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 6 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID324009Gastric-ulcerogenic effect in Wistar rat at 50 mg/kg, po2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
AID536432Antiinflammatory activity in Swiss albino mouse macrophage assessed as inhibition of LPS-induced IL-6 production at 1 ug/ml treated 30 mins before LPS challenge measured after 24 hrs by ELISA2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis and anti-inflammatory activity of derivatives of coumarino-lignoid, cleomiscosin A and its methyl ether.
AID592593Gastrointestinal toxicity in Wistar rat assessed as ulcer area of <1 mm diameter at 50 mg/kg, po2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID1221798Genotoxicity in HEK293 cells expressing UGT1A3 assessed as DNA strand breaks at 0.1 mM after 24 hrs by comet assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1275794Antibiofilm activity against Candida glabrata ATCC 15126 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID735609Analgesic activity in albino rat assessed as increase in tail withdrawal latency at 20 mg/kg, po after 1 hr relative to control2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
AID558031Drug concentration in human plasma2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Identification and characterization of mefloquine efficacy against JC virus in vitro.
AID417468Peripheral analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing response at 20 mg/kg, po administered 30 mins before acetic acid challenge measured after 3 hrs relative to control2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID1220799Drug metabolism in gallbladder-cannulated mouse assessed as glucuronide concentration in bile and urine at 0.2 mg/kg, iv up to 24 hrs by LC/MS/MS analysis2011Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 39, Issue:5
Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
AID1292791Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 9 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID592584Aqueous solubility of the compound in acetate buffer at pH 5.5 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID371929Analgesic activity in Wister albino rat at 20 mg/kg, po after 1 hr by tail-flick test2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID371936Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 10 mg/kg, po after 1 hr2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID436658Analgesic activity in mouse assessed as protection against acetic acid-induced writhing at 5 mg/kg, sc administered 30 mins before acetic acid challenge measured after 2 hrs relative to control2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
AID598521Inhibition of ovine COX2 assessed as PGF2alpha production from PGH2 after 5 mins by enzyme immunoassay2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
AID371941Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg, po after 3 hrs2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID1292416Tmax in healthy volunteer (3 volunteers) assessed as 3'-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID664971Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw edema at 50 mg/kg, po administered 1 hr prior to carrageenan-challenge measured after 3 hrs2012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID1292412Total drug excretion in healthy volunteer (3 volunteers) urine assessed as 5-hydroxy diclofenac at 100 mg, po administered as single dose measured over 96 hrs by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID558030Drug concentration in human brain2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Identification and characterization of mefloquine efficacy against JC virus in vitro.
AID1437581Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, po preincubated for 1 hr followed by carrageenan challenge measured at 2 hrs by plethysmometer relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID644996Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 50 mg/kg after 4 hrs by plethysmography relative to controlchallenge by plethysmography2012European journal of medicinal chemistry, Apr, Volume: 50Design, synthesis, computational and biological evaluation of some new hydrazino derivatives of DHA and pyranopyrazoles.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID1275782Antibiofilm activity against Candida albicans ATCC 10231 by two dimensional checkerboard dilution method2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292782Plasma concentration in healthy subject (7 subjects) at 50 mg, po administered as single dose measured after 3.5 hrs by gas chromatography1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID371935Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg, po after 30 mins2009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
AID491110Antiinflammatory activity in albino rat assessed as inhibition of carrageenan-induced paw oedema at 24 mmol/kg, ip administered 1 hr before carrageenan challenge measured after 3 hrs relative to control2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID1739507Inhibition of COX2 in PMA/LPS-stimulated human THP1 cells assessed as 6-keto-PGF1alpha production at 300 uM measured after 48 hrs by ELISA2020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID1221801Cytotoxicity against human hepatocytes assessed as cell viability at 1 mM relative to control2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1292775Total volume of distribution in healthy subject (7 subjects) at 50 mg, iv by three compartment open model1979European journal of clinical pharmacology, , Volume: 16, Issue:6
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
AID592588Partition coefficient, log P of the compound in octanol/0.1 M citric acid buffer at pH 3 by HPLC analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
AID478510Analgesic activity in Swiss albino mouse assessed as protection against acetic acid-induced writhing at 20 mg/kg, po after 1 hr2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
AID1592996Selectivity index, ratio of IC50 for ovine COX1 to IC50 for human recombinant COX22019European journal of medicinal chemistry, Apr-01, Volume: 167Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
AID324004Antiinflammatory activity against carrageenan-induced paw edema in orally dosed Wistar rat after 2 hrs relative to control2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
AID746387Antiinflammatory activity against carrageenan-induced Wistar rat paw edema model assessed as mean paw volume at 50 mg/kg, po after 3 hrs (Rvb =1.38 +/- 0.01 ml)2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents.
AID1437583Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, po preincubated for 1 hr followed by carrageenan challenge measured at 4 hrs by plethysmometer relative to control2017Journal of natural products, 01-27, Volume: 80, Issue:1
Exploring the Bioactive Terpenoid Content of an Algerian Plant of the Genus Pulicaria: The ent-Series of Asteriscunolides.
AID664974Antiinflammatory activity in po dosed albino rat assessed as inhibition of carrageenan-induced paw edema administered 1 hr prior to carrageenan-challenge measured after 3 hrs2012European journal of medicinal chemistry, Jul, Volume: 53New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
AID598518Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of carrageenan-induced foot paw oedema at 100 mg/kg, ip after 2 hrs by plethysmometer analysis relative to control2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
AID1193496Thermodynamic equilibrium solubility, log S of the compound in water at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID346302Toxicity in Albino rat assessed as induction of gastric ulceration at 300 mg/kg, po twice a day after 2 hrs2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
AID1221788Cytotoxicity against human hepatocytes assessed as decrease in cell viability by measuring intracellular ATP content at 0.1 mM measured at 6 hrs by CellTiter-Glo luminescent assay in absence of acyl glucuronidation inhibitor (-)-borneol2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
AID1430593Antirheumatoid arthritic activity in patient assessed as disease activity score at 50 mg, po bid for 8 weeks (Rvb = 6.72 +/- 0.87 No_unit)2017ACS medicinal chemistry letters, May-11, Volume: 8, Issue:5
Curcumin May (Not) Defy Science.
AID491113Toxicity in albino rat at 20 mg/kg, ip assessed as ulcerogenicity2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.
AID1292422Tmax in healthy volunteer (3 volunteers) assessed as 4',5-dihydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID693847Toxicity in Wistar albino rat assessed as ulcer index at 75 mg/kg/day, po administered for 4 days measured after 12 hrs fasting post-last dose2012Bioorganic & medicinal chemistry letters, Nov-01, Volume: 22, Issue:21
Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
AID1739534Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 24 hrs by MTS assay2020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID1125011Analgesic activity in Swiss Albino mouse assessed as inhibition of acetic acid-induced writhing at 25 mg/kg, po administered 30 mins before to acetic acid challenge measured for 15 mins relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
AID1292410Cmax in healthy volunteer (3 volunteers) assessed as 5-hydroxy diclofenac at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1275821Antibiofilm activity against Candida glabrata ATCC 15126 assessed as fractional inhibitory concentration by two dimensional checkerboard dilution method in presence of anidulafungin2016Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp.
AID1292395AUC (0 to 96 hrs) in healthy volunteer (3 volunteers) at 100 mg, po administered as single dose by capillary column gas chromatographic method1988Xenobiotica; the fate of foreign compounds in biological systems, Dec, Volume: 18, Issue:12
Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
AID1211841Total biliary clearance in iv dosed human after 8 hrs by T-tube method2013Drug metabolism and disposition: the biological fate of chemicals, Feb, Volume: 41, Issue:2
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
AID294733Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 90 mins by Eddy's hot plate technique2007European journal of medicinal chemistry, Jun, Volume: 42, Issue:6
Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (105)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.90)18.7374
1990's1 (0.95)18.2507
2000's23 (21.90)29.6817
2010's67 (63.81)24.3611
2020's12 (11.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 117.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index117.71 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index263.41 (26.88)
Search Engine Supply Index2.53 (0.95)

This Compound (117.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews3 (2.88%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
Other101 (97.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]